Veracyte, Inc.
VCYTNasdaqCIK 1384101HealthcareFiscal year ends Dec 31
All transactions: 7
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-28 | Wygant JonathanVP, Chief Accounting Officer, Officer | Tax withholding | 1,306 | $50.31 | $65.7k | Form 4 |
| 2026-10-27 | Eastham KarinDirector | Sale | 14,850 | $50.0049 | $742.6k | Form 4 |
| 2026-10-27 | Eastham KarinDirector | Option exercise | 10,000 | $27.01 | $270.1k | Form 4 |
| 2026-10-27 | Holstein JensDirector | Sale | 7,500 | $50.00 | $375.0k | Form 4 |
| 2026-10-27 | Holstein JensDirector | Option exercise | 7,500 | $35.30 | $264.8k | Form 4 |
| 2026-09-24 | Holstein JensDirector | Sale | 7,500 | $47.00 | $352.5k | Form 4 |
| 2026-09-24 | Holstein JensDirector | Option exercise | 7,500 | $35.30 | $264.8k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.